Zobrazeno 1 - 10
of 16
pro vyhledávání: '"James E. Gervasoni"'
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Publikováno v:
Cancer Investigation. 21:452-464
In the past, cancers of the anal canal were treated by radical surgery, principally abdominoperineal resection (APR). This modality of treatment was an extension of the Miles procedure adopted for ...
Publikováno v:
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 8(5)
Pancreaticoduodenectomy for pancreatic carcinoma after complicated open Roux-en-Y gastric bypass surgery: an alternative approach to reconstruction Ioannis Theodoropoulos, M.D.*, Charles Franco, M.D., James E. Gervasoni Jr, Ph.D., M.D. Department of
Autor:
John L. Tonkinson, C. A. Stein, Robert N. Taub, Leonid A. Yakubov, Susan A. Rotenberg, Li Ming Zhang, James E. Gervasoni
Publikováno v:
Biochemistry. 32:4855-4861
We have examined the cellular association and internalization of phosphodiester (PO) oligodeoxynucleotides (oligos) with HL60 cells. At 4 degrees C, a 15-mer PO homopolymer of thymidine (FOdT15) exhibits apparent saturation binding (Km = 22 +/- 1 nM)
Publikováno v:
Annals of surgical oncology. 14(9)
The role of lymphadenectomy as an adjunct of standard excision for treatment of cancer is highly debated and controversial. Standard practice for treatment of solid tumors is resection with regional lymphadenectomy. This surgical concept assumes that
Publikováno v:
Journal of Surgical Research. 65:31-33
Features of autoimmunity in abdominal aortic aneurysm (AAA) have been described, including increases in IgG content. The present experiments were carried out to determine (1) whether the increases in IgG are subclass specific and (2) whether the IgG
Autor:
James E, Gervasoni, Alexander A, Hindenburg, Michael P, Vezeridis, Scott, Schulze, Harold J, Wanebo, Shashikant, Mehta
Publikováno v:
Anticancer research. 24(5A)
The highly metastatic human pancreatic cell line L3.6 was used to study mechanisms for antitumor activity with various chemotherapeutic drug combinations. The most effective drugs were daunorubicin (IC50 0.4 microM), doxorubicin (IC50 22 microM), pac
Autor:
James E, Gervasoni, Harold J, Wanebo
Publikováno v:
Cancer investigation. 21(3)